A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Study of the Complexation of Mercury(II) with Dicysteinyl Tetrapeptides by Electrospray Ionization Mass Spectrometry

6.9K views

⸱

DOI:

10.3791/53536

⸱

January 8th, 2016

In This Article

Summary

The characterization of complexes formed in different relative ratios of mercury(II) to dicysteinyl tetrapeptides by electrospray ionization orbitrap mass spectrometry is presented.

Abstract

In this study we evaluated a method for the characterization of complexes, formed in different relative ratios of mercury(II) to dicysteinyl tetrapeptide, by electrospray ionization orbitrap mass spectrometry. This strategy is based on previous successful characterization of mercury-dicysteinyl complexes involving tripeptides by utilizing mass spectrometry among other techniques. Mercury(II) chloride and a dicysteinyl tetrapeptide were incubated in a degassed buffered medium at varying stoichiometric ratios. The complexes formed were subsequently analyzed on an electrospray mass spectrometer consisting of a hybrid linear ion- and orbi- trap mass analyzer. The electrospray ionization mass spectrometry (ESI-MS) spectra were acquired in the positive mode and the observed peaks were then analyzed for distinct mercury isotopic distribution patterns and associated monoisotopic peak. This work demonstrates that an accurate stoichiometry of mercury and peptide in the complexes formed under specified electrospray ionization conditions can be determined by using high resolution ESI MS based on distinct mercury isotopic distribution patterns.

Introduction

Current clinical drugs prescribed for chelation therapy of mercury poisoning1 contain thiol group(s), which is/are responsible for binding and sequestering mercury ions2,3. However, studies have shown that these small thiol compounds [dimercaptosuccinic acid (DMSA) and dimercaptopropane-sulfonic acid (DMPS)] are not optimal for mercury chelation therapy4-6. Therefore, there is a need to understand the association and complex formation tendencies of mercury with thiols to enhance the rational drug design of thiol compounds for mercury chelation. Recently, we reported that n-alkyl and aryl dicysteinyl tripeptides with dithiol....

Access restricted. Please log in or start a trial to view this content.

Protocol

Note: Please consult all relevant material safety data sheets (MSDS) before use. Mercury chloride is a toxic chemical. Personal protective equipment (gloves, safety goggles, and lab coat) must be worn when handing it and all associated solutions. Dispose of solutions in clearly labeled chemical waste bottles designated for heavy metals.

1. Preparation of 5 mM Degassed Ammonium Formate Buffer, pH 7.5

  1. Dissolve 0.1576 g of ammonium formate buffer in 450 ml of HPLC grade water. Adjust the pH of the above solution with 1 M formic acid and 1 M ammonium hydroxide to 7.5. Transfer this solution to a 500 ml volumetric flask and add HPLC ....

Access restricted. Please log in or start a trial to view this content.

Results

A study was performed to characterize the possible mercury-peptide complex composition for two tetrapeptides, CGGC and CEEC (Figure 1) by ESI mass spectrometry. Complexes of mercury(II) with CGGC or CEEC were investigated by reacting the mixtures of mercury(II) and peptide solutions at three different molar ratios: 1:0.5, 1:1, and 1:2 (mercury(II): peptide). The concentration of mercury(II) was 7.5 x 10-6 M and the peptide concentration varied accordingly.

.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The hydrophobic dicysteinyl tetrapeptide CGGC (C10H18N4O5S2; MW = 338) (Figure 1), forms complexes with mercury(II) as shown in Figure 2 and Table 1. Additionally, it forms peptide dimers and trimers incrementally as the amount of peptide increases in the reaction mixture. As shown by the m/z values of the associated dimers [(2M+H)+ = 677] and trimers [(3M+H)+ = 1015], the thiol groups of CGGC d.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

There is no disclosure for the work reported.

Acknowledgements

M.N-S acknowledges support from the National Science Foundation, RUI grant CHE 1011859. The authors gratefully acknowledge the Triad Mass Spectrometry Facility at the University of North Carolina at Greensboro for use of the Thermo Fisher Scientific LTQ Orbitrap XL mass spectrometer. The authors thank Daniel Todd, Vincent Sica, and Brandie Erhmann at the University of North Carolina at Greensboro for helpful suggestions and comments regarding this work.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Mercury(II) chlorideSigma-Aldrich429724Highly toxic
Ammonium formateSigma-Aldrich516961
Formic acidSigma-AldrichF0507
Ammonium hydroxideFisherA512-P500
HPLC waterFisherW5-4
HPLC AcetonitrileFisherBP2405-1
HPLC MethanolFisherA452-4

References

  1. Clifton, J. C. Mercury exposure and public health. Pediatr. Clin. N. Am. 54, 237-269 (2007).
  2. Andersen, O. Principles and Recent Developments in Chelation Treatment of Metal Intoxication. Chem. Rev. 99, 2683-2710 (1999).
  3. Aposhian, H. V., Maiorino, R. M., Gonzal....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Mercury(II) ComplexationOrbitrap Mass SpectrometryMercury Isotopic DistributionPeptide Complex AnalysisTandem Mass SpectrometryBuffer DegassingSample PreparationCharge State AnalysisMetal Ion Chelation